Does BICALUTAMIDE Cause Interstitial lung disease? 118 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Interstitial lung disease have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 2.9% of all adverse event reports for BICALUTAMIDE.
118
Reports of Interstitial lung disease with BICALUTAMIDE
2.9%
of all BICALUTAMIDE reports
41
Deaths
65
Hospitalizations
How Dangerous Is Interstitial lung disease From BICALUTAMIDE?
Of the 118 reports, 41 (34.7%) resulted in death, 65 (55.1%) required hospitalization, and 15 (12.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for BICALUTAMIDE.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Prostatic specific antigen increased (322)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BICALUTAMIDE Alternatives Have Lower Interstitial lung disease Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE